Navigation Links
Cynthia Nixon to Serve as Ambassador for Susan G. Komen for the Cure(R)
Date:4/15/2008

DALLAS, April 15 /PRNewswire/ -- Award-winning actress, Cynthia Nixon, best known for her role as Miranda on the long-running television series Sex and the City, joins Susan G. Komen for the Cure, the world's largest breast cancer advocacy organization, as an Ambassador. Nixon will share her personal experience with breast cancer, attend key events and reach millions through a series of TV and radio Public Service Announcements designed to educate people about the deadly disease and help engage them in Komen for the Cure's global breast cancer movement.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080415/LATU058)

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

"Over the next 25 years, an estimated 25 million women around the world will be diagnosed with breast cancer and 10 million could die from the disease," said breast cancer survivor Hala Moddelmog, president and CEO at Komen for the Cure. "Cynthia's personal story will certainly help draw attention to the impact of the disease as she joins the global breast cancer movement and our millions of survivors and activists working daily through Susan G. Komen for the Cure to create a world without breast cancer."

Nixon won an Emmy Award for her work on Sex and the City and a 2006 Tony Award as Best Actress in a leading role for David Lindsay-Abaire's Pulitzer prize-winning play, Rabbit Hole. She stars in the upcoming Sex and the City: The Movie scheduled for release on May 30 by New Line Cinema.

"As the daughter of a breast cancer survivor, knowing my personal risk made me more aware and more empowered when I faced my own diagnosis," said Nixon. "I want to help Susan G. Komen for the Cure educate the 1.1 million women around the globe who face a diagnosis each year. Even if breast cancer doesn't run in your family -- take charge. Talk with your doctor, make healthy lifestyle choices and most importantly, know your body as that can make all the difference in the world."

In a series of intimate Web videos available for viewing at komen.org/cynthia, Nixon will share personal excerpts from her journey. Her candid dialogue serves to empower all to take action in the war on breast cancer.

About Susan G. Komen for the Cure(R)

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, we have invested more than $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit http://www.komen.org or call 1-877 GO KOMEN.


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Transplant Network Appoints Cynthia Siljestrom CEO
2. Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer
3. Cynthia Steedman Earns Health Care Fraud Investigator Accreditation
4. Mark Leventhal To Address Nixon Peabody LLP
5. Want docs to treat the underserved? Make sure they train at community health centers
6. Expansion of monocyte subset could serve as a biomarker for HIV progressions
7. Western Reserve Heart Care Receives ICANL Nuclear Medicine Accreditation
8. AMERIGROUP Updates 2008 Guidance to Reflect Yesterdays Federal Reserve Action
9. Body Mass Index may serve as prognostic tool for advanced, aggressive breast cancers
10. Author Elizabeth Golden and Dancer Sarah Patellos to Serve as National Spokespersons for the National Scoliosis Foundation
11. Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 04, 2016 , ... Safety ... global construction firms representing the Construction Industry Safety Initiative (CISI) and the Incident ... purpose: to inspire everyone in the industry to be leaders in safety. Statistics ...
(Date:5/3/2016)... ... May 04, 2016 , ... The National Association ... into its VIP Woman of the Year Circle. She is recognized with this prestigious ... professional women, boasting more than 850,000 members and over 200 operating Local Chapters. , ...
(Date:5/3/2016)... ... May 03, 2016 , ... According to an article ... issues related to medical care in the hospital setting, which include excessive wait ... hospital staff. Commenting on this article, the founder of House Call Doctor Los ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... 2016 Champion Award to Charles D. Pulido, R.Ph., Co-Founder of NCPDP and member ... Ph.D., Pharmacy Advisor and Health IT Specialist, Office of the National Coordinator for ...
(Date:5/3/2016)... Redondo Beach, CA (PRWEB) , ... May 03, 2016 , ... ... together online to help cancer patients and their families move toward recovery and is ... the focus of today's Dr. Carol Francis Talk Radio show considering medical ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... YORK , May 2, 2016 Kalorama ... EMR (Electronic Medical Records) market in a recent white ... sales, vendor switches, Increased physician usage, a growing market are ... were noted in Kalorama,s report EMR 2016: ... report marks Kalorama,s seventh complete study of the EMR ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
Breaking Medicine Technology: